NEW YORK (GenomeWeb News) – Finnish biotech firm Biohit said on Monday it has agreed to buy Euroclone Gastro, a subsidiary of Italian firm Euroclone that is focused on gastrointestinal diagnostics.

The deal is anticipated to close this month. Following its completion, Euroclone Gastro will form a Biohit-owned subsidiary, Biohit Healthcare, to support the distribution of Biohit's diagnostic products in Italy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.